GOT1 and pulmonary arterial hypertension: Meanwhile, Medioresinol (MDN) promoted Phe metabolism by increasing the expression of GOT1 and PAH after cerebral ischemia, and inhibited the apoptosis of cerebral microvascular endothelial cells (16).